147 related articles for article (PubMed ID: 12198151)
1. Suppression of the STK15 oncogenic activity requires a transactivation-independent p53 function.
Chen SS; Chang PC; Cheng YW; Tang FM; Lin YS
EMBO J; 2002 Sep; 21(17):4491-9. PubMed ID: 12198151
[TBL] [Abstract][Full Text] [Related]
2. The centrosomal kinase Aurora-A/STK15 interacts with a putative tumor suppressor NM23-H1.
Du J; Hannon GJ
Nucleic Acids Res; 2002 Dec; 30(24):5465-75. PubMed ID: 12490715
[TBL] [Abstract][Full Text] [Related]
3. Frequent overexpression of STK15/Aurora-A/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian cancer.
Hu W; Kavanagh JJ; Deaver M; Johnston DA; Freedman RS; Verschraegen CF; Sen S
Oncol Res; 2005; 15(1):49-57. PubMed ID: 15839305
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53.
Katayama H; Sasai K; Kawai H; Yuan ZM; Bondaruk J; Suzuki F; Fujii S; Arlinghaus RB; Czerniak BA; Sen S
Nat Genet; 2004 Jan; 36(1):55-62. PubMed ID: 14702041
[TBL] [Abstract][Full Text] [Related]
5. Aurora-A abrogation of p53 DNA binding and transactivation activity by phosphorylation of serine 215.
Liu Q; Kaneko S; Yang L; Feldman RI; Nicosia SV; Chen J; Cheng JQ
J Biol Chem; 2004 Dec; 279(50):52175-82. PubMed ID: 15469940
[TBL] [Abstract][Full Text] [Related]
6. Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutants.
Inga A; Resnick MA
Oncogene; 2001 Jun; 20(26):3409-19. PubMed ID: 11423991
[TBL] [Abstract][Full Text] [Related]
7. Dynamic association of a tumor amplified kinase, Aurora-A, with the centrosome and mitotic spindle.
Stenoien DL; Sen S; Mancini MA; Brinkley BR
Cell Motil Cytoskeleton; 2003 Jun; 55(2):134-46. PubMed ID: 12740874
[TBL] [Abstract][Full Text] [Related]
8. Direct evidence for the role of centrosomally localized p53 in the regulation of centrosome duplication.
Shinmura K; Bennett RA; Tarapore P; Fukasawa K
Oncogene; 2007 May; 26(20):2939-44. PubMed ID: 17072342
[TBL] [Abstract][Full Text] [Related]
9. Aurora-A overexpression reveals tetraploidization as a major route to centrosome amplification in p53-/- cells.
Meraldi P; Honda R; Nigg EA
EMBO J; 2002 Feb; 21(4):483-92. PubMed ID: 11847097
[TBL] [Abstract][Full Text] [Related]
10. Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2.
Dumaz N; Meek DW
EMBO J; 1999 Dec; 18(24):7002-10. PubMed ID: 10601022
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation.
Wang X; Zhou YX; Qiao W; Tominaga Y; Ouchi M; Ouchi T; Deng CX
Oncogene; 2006 Nov; 25(54):7148-58. PubMed ID: 16715125
[TBL] [Abstract][Full Text] [Related]
12. Association of centrosomal kinase STK15/BTAK mRNA expression with chromosomal instability in human breast cancers.
Miyoshi Y; Iwao K; Egawa C; Noguchi S
Int J Cancer; 2001 May; 92(3):370-3. PubMed ID: 11291073
[TBL] [Abstract][Full Text] [Related]
13. Amplification/overexpression of a mitotic kinase gene in human bladder cancer.
Sen S; Zhou H; Zhang RD; Yoon DS; Vakar-Lopez F; Ito S; Jiang F; Johnston D; Grossman HB; Ruifrok AC; Katz RL; Brinkley W; Czerniak B
J Natl Cancer Inst; 2002 Sep; 94(17):1320-9. PubMed ID: 12208897
[TBL] [Abstract][Full Text] [Related]
14. Repression of glucocorticoid receptor transactivation and DNA binding of a glucocorticoid response element within the serum/glucocorticoid-inducible protein kinase (sgk) gene promoter by the p53 tumor suppressor protein.
Maiyar AC; Phu PT; Huang AJ; Firestone GL
Mol Endocrinol; 1997 Mar; 11(3):312-29. PubMed ID: 9058378
[TBL] [Abstract][Full Text] [Related]
15. [The over-expression of serine/threonine kinase 15 protein in oral carcinogenesis].
Lu H; Cai Y; Yu YN; Yang H
Hua Xi Kou Qiang Yi Xue Za Zhi; 2009 Feb; 27(1):88-91. PubMed ID: 19323405
[TBL] [Abstract][Full Text] [Related]
16. Identification of Stk6/STK15 as a candidate low-penetrance tumor-susceptibility gene in mouse and human.
Ewart-Toland A; Briassouli P; de Koning JP; Mao JH; Yuan J; Chan F; MacCarthy-Morrogh L; Ponder BA; Nagase H; Burn J; Ball S; Almeida M; Linardopoulos S; Balmain A
Nat Genet; 2003 Aug; 34(4):403-12. PubMed ID: 12881723
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic role of nuclear accumulated Aurora-A.
Tatsuka M; Sato S; Kanda A; Miki T; Kamata N; Kitajima S; Kudo Y; Takata T
Mol Carcinog; 2009 Sep; 48(9):810-20. PubMed ID: 19204928
[TBL] [Abstract][Full Text] [Related]
18. High-throughput screening assay for identification of small molecule inhibitors of Aurora2/STK15 kinase.
Sun C; Newbatt Y; Douglas L; Workman P; Aherne W; Linardopoulos S
J Biomol Screen; 2004 Aug; 9(5):391-7. PubMed ID: 15296638
[TBL] [Abstract][Full Text] [Related]
19. Abnormal centrosome amplification and Aurora-A activation in p53-deficient cells.
Oda-Sato E; Tanaka N
J Nippon Med Sch; 2007 Dec; 74(6):384-5. PubMed ID: 18084130
[No Abstract] [Full Text] [Related]
20. Survivin inhibits anti-growth effect of p53 activated by aurora B.
Jung JE; Kim TK; Lee JS; Oh SY; Kwak S; Jin X; Sohn JY; Song MK; Sohn YW; Lee SY; Pian X; Lee JB; Chung YG; Choi YK; You S; Kim H
Biochem Biophys Res Commun; 2005 Nov; 336(4):1164-71. PubMed ID: 16171786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
